901124-77-4Relevant academic research and scientific papers
6-[123I]Iodo-2-[[4-(2-methoxyphenyl) piperazin-1-yl]methyl] imidazo[1,2-a]pyridine as potential SPECT agent for imaging dopamine D 4 receptor: Synthesis and in vivo evaluation in a nonhuman primate
Alagille, David,Koren, Andrei O.,Kudej, Greg,Staley, Julie,Cosgrove, Kelly,Seibyl, John,Tamagnan, Gilles D.
, p. 202 - 206 (2008/09/20)
The dopamine O4 receptor subtype has drawn considerable attention due to its potential implication in schizophrenia and erectile dysfunction. 6-[123I]Iodo-2-[[4-(2-methoxyphenyl)piperazin-1-yl] methyl]imidazo[1,2-a]pyridine [123
2-[(4-Phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D 4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl) piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist
Enguehard-Gueiffier, Cécile,Hübner, Harald,El Hakmaoui, Ahmed,Allouchi, Hassan,Gmeiner, Peter,Argiolas, Antonio,Melis, Maria Rosaria,Gueiffier, Alain
, p. 3938 - 3947 (2007/10/03)
A series of novel 2-[(4-phenylpiperazin-1-yl)methyl]imidazoazines and aza-analogues were prepared and screened at selected dopamine, serotonin, and adrenergic receptor subtypes. 2-Substituted imidazopyridines and pyridazines presented high affinities and
